Pancreatic Adenocarcinoma Pac clinical trials

Explore recruiting pancreatic adenocarcinoma pac clinical trials.

Recruiting pancreatic adenocarcinoma pac studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pancreatic Adenocarcinoma Pac trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

GEMFOX - Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for FOLFIRINOX

France

Phase II and Phase III (Integrated) EU CTIS Study details

Pancreatic Adenocarcinoma Pac trials by city

Pancreatic Adenocarcinoma Pac in Toronto Pancreatic Adenocarcinoma Pac in Vancouver Pancreatic Adenocarcinoma Pac in Montreal Pancreatic Adenocarcinoma Pac in Calgary Pancreatic Adenocarcinoma Pac in Edmonton Pancreatic Adenocarcinoma Pac in Ottawa Pancreatic Adenocarcinoma Pac in Winnipeg Pancreatic Adenocarcinoma Pac in Quebec City Pancreatic Adenocarcinoma Pac in Hamilton Pancreatic Adenocarcinoma Pac in Kitchener Pancreatic Adenocarcinoma Pac in London Pancreatic Adenocarcinoma Pac in Halifax Pancreatic Adenocarcinoma Pac in New York Pancreatic Adenocarcinoma Pac in Los Angeles Pancreatic Adenocarcinoma Pac in Chicago Pancreatic Adenocarcinoma Pac in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease